Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bacteriology
Biacticap is the latest weapon in the fight against MRSA
June 17th, 2005
The National Health Service (NHS) has stated publicly that it will leave no stone unturned in its fight against the "superbug" methicillin-resistant Staphylococcus aureus (MRSA). Now, a new weapon is available to the NHS armory in the form of a permanent biocidal coating called Biacticap, which is 99.8% effective in limiting the growth of MRSA. Developed by Carrs Products, a Midlands-based manufacturer of coated papers, Biacticap is also effective against other harmful bacteria including listeria, E. coli and salmonella. Resistant bacteria such as MRSA represent a growing global threat that is extremely costly in...
Source: Drug Week (2005-06-17)
|
